Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study

por Cassandra, Rayer, Nachury, Maria, Arnaud, Bourreille, Xavier, Roblin, Laurent, Peyrin-Biroulet, Stephanie, Viennot, Mathurin, Flamant, David, Laharie, Bénédicte, Caron, Marie, Dewitte, Laurent, Siproudhis, Mathurin, Fumery, Guillaume, Bouguen
Publicado 2022